Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 2-3/2009

01.06.2009

The Role of Complement in the Antiphospholipid Syndrome-Associated Pathology

verfasst von: Ingrid Avalos, George C. Tsokos

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2-3/2009

Einloggen, um Zugang zu erhalten

Abstract

The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thromboses, pregnancy loss, and the presence of anticardiolipin antibodies. The pathogenic mechanisms that lead to these clinical manifestations are incompletely understood. Although a direct pathogenic role of antiphospholipid antibodies has been established, including their role in endothelial cell and platelet activation, there is growing evidence that activation of the complement pathway may contribute to the pathogenesis of APS. Vital information has been obtained from studies exploring the features of pregnancy morbidity and thrombosis using complement deficient murine models. These studies are providing the foundation for the development of new therapeutic options to optimize the management of APS.
Literatur
1.
Zurück zum Zitat Kim YU, Kinoshita T, Molina H et al (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181(1):151–159, January 1PubMedCrossRef Kim YU, Kinoshita T, Molina H et al (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181(1):151–159, January 1PubMedCrossRef
2.
Zurück zum Zitat Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H (2000) A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287(5452):498–501, January 21PubMedCrossRef Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H (2000) A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287(5452):498–501, January 21PubMedCrossRef
3.
Zurück zum Zitat Lockshin MD, Sammaritano LR, Schwartzman S (2000) Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 43(2):440–443, FebruaryPubMedCrossRef Lockshin MD, Sammaritano LR, Schwartzman S (2000) Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 43(2):440–443, FebruaryPubMedCrossRef
4.
Zurück zum Zitat Holers VM, Girardi G, Mo L et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195(2):211–220, January 21PubMedCrossRef Holers VM, Girardi G, Mo L et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195(2):211–220, January 21PubMedCrossRef
5.
Zurück zum Zitat Girardi G, Berman J, Redecha P et al (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112(11):1644–1654, DecemberPubMed Girardi G, Berman J, Redecha P et al (2003) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112(11):1644–1654, DecemberPubMed
6.
Zurück zum Zitat Kirchhofer D, Moran P, Bullens S, Peale F, Bunting S (2005) A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost 3(5):1098–1099, MayPubMedCrossRef Kirchhofer D, Moran P, Bullens S, Peale F, Bunting S (2005) A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost 3(5):1098–1099, MayPubMedCrossRef
7.
Zurück zum Zitat Pawlinski R, Pedersen B, Erlich J, Mackman N (2004) Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost 92(3):444–450, SeptemberPubMed Pawlinski R, Pedersen B, Erlich J, Mackman N (2004) Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost 92(3):444–450, SeptemberPubMed
8.
Zurück zum Zitat Shamonki JM, Salmon JE, Hyjek E, Baergen RN (2007) Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 196(2):167.e1–167e.5, FebruaryCrossRef Shamonki JM, Salmon JE, Hyjek E, Baergen RN (2007) Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 196(2):167.e1–167e.5, FebruaryCrossRef
9.
Zurück zum Zitat Stone S, Pijnenborg R, Vercruysse L et al (2006) The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27(4-5):457–467, AprilPubMedCrossRef Stone S, Pijnenborg R, Vercruysse L et al (2006) The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta 27(4-5):457–467, AprilPubMedCrossRef
10.
Zurück zum Zitat Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52(7):2120–2124, JulyPubMedCrossRef Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52(7):2120–2124, JulyPubMedCrossRef
11.
12.
Zurück zum Zitat Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B (2006) Blood platelets activate the classical pathway of human complement. J Thromb Haemost 4(9):2035–2042, SeptemberPubMedCrossRef Peerschke EI, Yin W, Grigg SE, Ghebrehiwet B (2006) Blood platelets activate the classical pathway of human complement. J Thromb Haemost 4(9):2035–2042, SeptemberPubMedCrossRef
13.
Zurück zum Zitat Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1993) Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 218(4):444–453, OctoberPubMedCrossRef Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1993) Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg 218(4):444–453, OctoberPubMedCrossRef
14.
Zurück zum Zitat Crawford MH, Grover FL, Kolb WP et al (1988) Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78(6):1449–1458, DecemberPubMed Crawford MH, Grover FL, Kolb WP et al (1988) Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78(6):1449–1458, DecemberPubMed
15.
Zurück zum Zitat Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256(5053):105–107, April 3PubMedCrossRef Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256(5053):105–107, April 3PubMedCrossRef
16.
Zurück zum Zitat Fleming SD, Shea-Donohue T, Guthridge JM et al (2002) Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169(4):2126–2133, August 15PubMed Fleming SD, Shea-Donohue T, Guthridge JM et al (2002) Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169(4):2126–2133, August 15PubMed
17.
Zurück zum Zitat Fleming SD, Egan RP, Chai C et al (2004) Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 173(11):7055–7061, December 1PubMed Fleming SD, Egan RP, Chai C et al (2004) Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 173(11):7055–7061, December 1PubMed
18.
Zurück zum Zitat Williams JP, Pechet TT, Weiser MR et al (1999) Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86(3):938–942, MarchPubMed Williams JP, Pechet TT, Weiser MR et al (1999) Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86(3):938–942, MarchPubMed
19.
Zurück zum Zitat Stahl GL, Xu Y, Hao L et al (2003) Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 162(2):449–455, FebruaryPubMed Stahl GL, Xu Y, Hao L et al (2003) Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 162(2):449–455, FebruaryPubMed
20.
Zurück zum Zitat Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50(4):1028–1039, AprilPubMedCrossRef Derksen RH, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50(4):1028–1039, AprilPubMedCrossRef
21.
Zurück zum Zitat Edens RE, Linhardt RJ, Bell CS, Weiler JM (1994) Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology 27(2):145–153, MarchPubMedCrossRef Edens RE, Linhardt RJ, Bell CS, Weiler JM (1994) Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology 27(2):145–153, MarchPubMedCrossRef
22.
Zurück zum Zitat Weiler JM, Edens RE, Linhardt RJ, Kapelanski DP (1992) Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148(10):3210–3215, May 15PubMed Weiler JM, Edens RE, Linhardt RJ, Kapelanski DP (1992) Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148(10):3210–3215, May 15PubMed
23.
Zurück zum Zitat Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 67(1):223–228, JanuaryPubMedCrossRef Kazatchkine MD, Fearon DT, Metcalfe DD, Rosenberg RD, Austen KF (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. J Clin Invest 67(1):223–228, JanuaryPubMedCrossRef
24.
Zurück zum Zitat Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10(11):1222–1226, NovemberPubMedCrossRef Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10(11):1222–1226, NovemberPubMedCrossRef
Metadaten
Titel
The Role of Complement in the Antiphospholipid Syndrome-Associated Pathology
verfasst von
Ingrid Avalos
George C. Tsokos
Publikationsdatum
01.06.2009
Verlag
Humana Press Inc
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 2-3/2009
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-008-8109-7

Weitere Artikel der Ausgabe 2-3/2009

Clinical Reviews in Allergy & Immunology 2-3/2009 Zur Ausgabe

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.